Using cDNA microarray analysis, we demonstrated that HLJ1 deficiency alters hepatic gene signatures associated with chemical-induced liver cancer and IL-6/STAT3 signaling, and HLJ1 knockout mice showed pronounced STAT3 activation in normal liver adjacent to DEN-induced tumors. The gene discussed is STAT3; the disease is liver cancer.